Sharps Compliance Corp.'s Proven Patient Support Program is Designed to Address Requirements in Newly Passed Legislation in California

Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading provider of cost-effective disposal solutions for medical and pharmaceutical waste generated outside the hospital setting, commented on the passing of California Senate Bill 486. The bill requires pharmaceutical manufacturers, on or before July 1, 2010, who sell or distribute medications that are routinely injected at home to submit plans to the California Integrated Waste Management Board describing how they support and provide safe syringe and needle collection and disposal programs for their patients. The bill also requires the manufacturers to post those plans on their website.

Dr. Burton J. Kunik, Chairman and Chief Executive Officer of Sharps, commented, "California Senate Bill 486 is a significant step forward toward improving public awareness surrounding the proper containment and disposal of sharps and to promote a shared responsibility for end-of-life sharps products. We are proud to be at the forefront in addressing this issue through our relationships with many municipalities across California and the services we provide pharmaceutical manufacturers for enabling the cost-effective, easy-to-use, safe disposal solutions for sharps."

In the State of California, each year, approximately 389 million sharps, a type of medical waste that includes needles and syringes, are disposed of outside of traditional health care facilities by an estimated one million self-injectors. Although current laws in California prohibit the disposal of sharps in the solid waste or recycling stream, the majority are still disposed of improperly, causing damage to the environment and posing a severe risk of injury and disease to those who come in contact with used hypodermic needles, syringes and lancets.

Sharps provides a unique and proven Patient Support Program for pharmaceutical manufacturers that support their efforts to ensure the safe and effective use of the medications they have developed while also providing the patients a convenient means of disposing of their sharps. Sharps' vendor managed inventory program includes the direct fulfillment of the Sharps Disposal By Mail System(R) to the pharmaceutical manufacturers' self-injecting patient support program participants, who use the product as a convenient means of disposing of used syringes. The Company's SharpsTracer(TM) system tracks the return of the Sharps Disposal By Mail System(R) by the patient to the treatment facility, where the package is processed prior to destruction utilizing the Company's proprietary and customizable system. This data is electronically transmitted and available to the pharmaceutical manufacturer via the Company's proprietary data warehouse which assists the customer in monitoring drug usage and provides them with a touch point for individual patient follow-up.

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading provider of cost-effective disposal solutions for medical and pharmaceutical waste generated outside the hospital setting. The Company's flagship product, the Sharps Disposal by Mail System(R), is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps").

The Sharps(R)MWMS(TM), a Medical Waste Management System, is a comprehensive medical waste solution which includes an array of services and products necessary to effectively collect, store and dispose of medical waste outside of the hospital setting. The System, which is designed for rapid deployment, features the Sharps Disposal by Mail System(R) products combined with warehousing, inventory management, training, data and other services necessary to provide a comprehensive solution. The Sharps(R)MWMS(TM) is designed to be an integral part of governmental and commercial emergency preparedness programs.

The Company also offers a number of products specifically designed for the home healthcare market and products for the safe disposal of unused pharmaceuticals, RxTakeAway(TM). Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, commercial, and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps as well as unused pharmaceuticals in the community setting.

As a fully integrated manufacturer providing customer solutions and services, Sharps Compliance's solid business model, with strong margins and significant operating leverage, and early penetration into emerging markets, uniquely positions the company for strong future growth.

More information on Sharps Compliance can be found on its website at: www.sharpsinc.com

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Sharps Compliance, Inc.

CONTACT:  Sharps Compliance, Inc.
David P. Tusa, Executive Vice President,
Chief Financial Officer & Business Development
(713) 660-3514
dtusa@sharpsinc.com
Kei Advisors LLC
Investor Relations
Deborah Pawlowski
(716) 843-3908
dpawlowski@keiadvisors.com

Related terms: california, ceo, commercial, disease, emergency, health, healthcare, law, legislation, manufacturer, market, medical, nasdaq, pharmaceuticals, products, retail, senate, training, waste management